Target intelligence / Profile preview

Deoxyribonucleic acid and microtubules

Molecular classification
Nucleic acid, Cytoskeletal protein, Other
01

Overview

Deoxyribonucleic acid (DNA) and microtubules are two distinct but functionally interrelated cellular components that serve as primary targets for cytotoxic chemotherapy. DNA is the hereditary material in humans and almost all other organisms, providing the essential template for protein synthesis and cellular replication (National Human Genome Research Institute, 2023). Microtubules are dynamic cytoskeletal polymers composed of alpha- and beta-tubulin dimers that are essential for maintaining cell architecture, facilitating intracellular transport, and forming the mitotic spindle required for chromosome segregation during mitosis (Nature Education, 2014). Drugs targeting DNA, such as cisplatin or doxorubicin, function by forming covalent cross-links or intercalating between base pairs to inhibit replication and transcription (PubChem, 2024). Microtubule-targeting agents, including taxanes and vinca alkaloids, either stabilize or destabilize microtubule polymers, leading to cell cycle arrest at the metaphase-anaphase transition and subsequent apoptosis (StatPearls, 2023). Because both targets are vital for the rapid proliferation of malignant cells, they are frequently targeted in combination regimens to maximize therapeutic efficacy and overcome drug resistance in various cancers (PubMed, 2022).

Other names
DNA and tubulinDNA/Microtubule dual targetsGenetic material and cytoskeletal filaments
02

Mechanism of action

DNA alkylation, DNA intercalation, topoisomerase inhibition, microtubule stabilization, and microtubule destabilization leading to mitotic arrest and programmed cell death.

03

Biological functions

Cell cycleCell proliferationApoptosisGenetic information storageIntracellular transportMitosis
04

Disease associations

CancerInflammationAutoimmune disease
05

Safety considerations

Myelosuppression (neutropenia, leukopenia)Peripheral neuropathyNephrotoxicityCardiotoxicityAlopeciaGastrointestinal toxicitySecondary malignancies
06

Interacting drugs

Paclitaxel

8 more in the full profile.

07

Biomarkers

Ki-67 expressionTP53 mutation statusTUBB3 (Class III beta-tubulin) expressionBRCA1/2 mutation statusMicrosatellite instability (MSI) status

Beyond the preview

Go deeper on Deoxyribonucleic acid and microtubules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxyribonucleic acid and microtubules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call